Non-Animal Navigator™: Expert strategy and AI-enabled biosimulation to reduce, refine, or replace animal studies
Certara Non-Animal Navigator™ 解决方案通过以下方式助力企业转型：
Certara2025 年 4 月 30 日
Certara Announces Second Annual Certainty U.S. Event
Certara’s premier client conference explores how in-silico methods and biosimulation at scale derisk every stage…
Certara2025 年 4 月 22 日
In case you missed it: CHI + Certara Webinar on Artificial Intelligence (AI) -Powered Model-Informed Drug Development (MIDD)
2025 年 4 月 18 日 What’s next for drug development? Recapping our MIDD in the age of…
Certara2025 年 4 月 18 日
Certara Launches Non-Animal Navigator™ Solution to Help Drug Developers Reduce Reliance on Animal Testing
New offering provides strategic guidance and AI-enabled biosimulation to navigate FDA’s Roadmap to Reducing Animal…
Certara2025 年 4 月 14 日
Safety of combined long-acting injectable cabotegravir and long-acting injectable rilpivirine in virologically suppressed adolescents with HIV (IMPAACT 2017/MOCHA): a phase 1/2, multicentre, open-label, non-comparative, dose-finding study
The IMPAACT 2017/MOCHA study, a phase 1/2 multicenter trial across five countries, assessed the safety,…
Certara2025 年 3 月 20 日
How biosimulation and virtual trials can bust through clinical trial roadblocks
Discover how using biosimulation for rare disease drug development can help overcome statistical and recruitment…
Certara2025 年 3 月 14 日
MIDD in Japan – Implementations, challenges and opportunities
In Japan, there has been a growing adoption of Model Informed Drug Development (MIDD) approaches…
Certara2025 年 3 月 12 日
Model-Informed Drug Development in the Age of AI
Lorem ipsum dolor sit amet consectetur. Donec diam risus volutpat tempor. Massa accumsan aliquam nibh…
Certara2025 年 3 月 10 日
Postmarketing Assessment of Antibody–Drug Conjugates: Proof-of-Concept Using Model-Based Meta-Analysis and a Clinical Utility Index Approach
This study explores a model-based meta-analysis (MBMA) and a clinical utility index (CUI) approach to…
Certara2025 年 3 月 4 日
Machine Learning for PK/PD Modeling in Drug Development
Pharmacometricians can use machine learning for PK/PD modeling to help them characterize the safety and…
Certara2025 年 3 月 4 日
